We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$7.48B
1-Year Est. Return
104.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
(-5.5%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GeneDx Holdings
WGS
|
+$41.9M |
| 2 |
Generac Holdings
GNRC
|
+$40.9M |
| 3 |
Vaxcyte
PCVX
|
+$24.8M |
| 4 |
Teradyne
TER
|
+$24.8M |
| 5 |
UL Solutions
ULS
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$64.4M |
| 2 |
GE Vernova
GEV
|
+$42.1M |
| 3 |
Inspire Medical Systems
INSP
|
+$40.6M |
| 4 |
RNAM
Avidity Biosciences
RNAM
|
+$37.8M |
| 5 |
Lithia Motors
LAD
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.12% |
| 2 | Industrials | 19.41% |
| 3 | Technology | 15.63% |
| 4 | Energy | 7.14% |
| 5 | Consumer Discretionary | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Woodside Energy
WDS
$44B
| $289K | ﹤0.01% |
+11,923
| New | +$232K |
|
252
Steel Dynamics
STLD
$33.4B
| $285K | ﹤0.01% |
1,661
-1,750
| -51% | -$319K |
|
253
Protagonist Therapeutics
PTGX
$9.49B
| $279K | ﹤0.01% |
+2,795
| New | +$247K |
|
254
Sterling Infrastructure
STRL
$15.2B
| $275K | ﹤0.01% |
719
-1,596
| -69% | -$624K |
|
255
Stride
LRN
$3.56B
| $268K | ﹤0.01% |
+3,178
| New | +$258K |
|
256
Manhattan Associates
MANH
$13.1B
| $262K | ﹤0.01% |
2,007
+29
| +1% | +$4.34K |
|
257
Samsara
IOT
$24.4B
| $258K | ﹤0.01% |
8,406
-50,771
| -86% | -$1.55M |
|
258
Patrick Industries
PATK
$2.66B
| $239K | ﹤0.01% |
2,265
+66
| +3% | +$8.16K |
|
259
Credo Technology Group
CRDO
$44.1B
| $237K | ﹤0.01% |
2,698
-13,521
| -83% | -$1.65M |
|
260
PPG Industries
PPG
$25.3B
| $236K | ﹤0.01% |
2,277
+272
| +14% | +$30.8K |
|
261
Nutanix
NTNX
$18.8B
| $230K | ﹤0.01% |
6,057
+195
| +3% | +$8.22K |
|
262
Quest Diagnostics
DGX
$26.9B
| $219K | ﹤0.01% |
+1,112
| New | +$216K |
|
263
Entegris
ENTG
$21.7B
| $213K | ﹤0.01% |
+1,957
| New | +$231K |
|
264
HDFC Bank
HDB
$118B
| $208K | ﹤0.01% |
+8,633
| New | +$268K |
|
265
United Microelectronic
UMC
$50.9B
| $182K | ﹤0.01% |
+21,147
| New | +$206K |
|
266
FNB Corp
FNB
$6.6B
| $166K | ﹤0.01% |
+10,250
| New | +$177K |
|
267
MediaAlpha
MAX
$680M
| $165K | ﹤0.01% |
+17,509
| New | +$173K |
|
268
Northwest Bancshares
NWBI
$2.25B
| $146K | ﹤0.01% |
+11,568
| New | +$146K |
|
269
Aurora
AUR
$11.4B
| $143K | ﹤0.01% |
36,899
+18,114
| +96% | +$80.1K |
|
270
AvePoint
AVPT
$2.99B
| $142K | ﹤0.01% |
+15,133
| New | +$170K |
|
271
QuantumScape Corp
QS
$3.6B
| $120K | ﹤0.01% |
+20,182
| New | +$168K |
|
272
UiPath
PATH
$9.48B
| $116K | ﹤0.01% |
+10,716
| New | +$136K |
|
273
Capitol Federal Financial
CFFN
$1.07B
| $105K | ﹤0.01% |
+14,979
| New | +$107K |
|
274
Compass
COMP
$8.61B
| $75K | ﹤0.01% |
+10,956
| New | +$115K |
|
275
FTAI Infrastructure
FIP
$425M
| $52.8K | ﹤0.01% |
+11,209
| New | +$62.8K |
|
Similar funds
S
CCM
O
HI
HPC
FPP
RIG
TAM
Eventide Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.
Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.
- Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
- Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
- Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
- Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
- Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
- Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
- Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.
Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.